Nuveen, LLC Cytokinetics Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Nuveen, LLC holds 351,368 shares of CYTK stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351,368Holding current value
$11.9 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$498 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$402 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$338 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$271 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$206 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.19B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...